This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.



  • Response to chemotherapy can be predicted using patient-derived organoids

    There is a great need for a test that can predict which patients will respond to  chemotherapy and which will not. In a clinical study with 61 metastatic colorectal cancer patients, researchers from the Netherlands Cancer Institute, led by Emile Voest, now showed that a specific second-line chemotherapy treatment can first be tested on organoids: these are 'mini tumours' that have  been laboratory grown from a small piece of the same patients' tumour tissue.  

    Read More
  • NKI is recruiting (junior) group leaders

    The NKI has opened a call for two positions: one for a (junior) group leader in a research topic that synergizes with the ongoing research at the NKI and another one with a focus on immunology/inflammation.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us